- Home
- GDL vs ICAD Comparison
GDL vs ICAD Comparison
Compare GDL & ICAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDL
- ICAD
- Stock Information
- Founded
- GDL 2006
- ICAD 1984
- Country
- GDL United States
- ICAD United States
- Employees
- GDL N/A
- ICAD N/A
- Industry
- GDL Investment Managers
- ICAD Medical/Dental Instruments
- Sector
- GDL Finance
- ICAD Health Care
- Exchange
- GDL Nasdaq
- ICAD Nasdaq
- Market Cap
- GDL 89.3M
- ICAD 93.9M
- IPO Year
- GDL N/A
- ICAD 1986
- Fundamental
- Price
- GDL $8.16
- ICAD $3.68
- Analyst Decision
- GDL
- ICAD Hold
- Analyst Count
- GDL 0
- ICAD 1
- Target Price
- GDL N/A
- ICAD N/A
- AVG Volume (30 Days)
- GDL 11.2K
- ICAD 1.8M
- Earning Date
- GDL 01-01-0001
- ICAD 05-19-2025
- Dividend Yield
- GDL 6.02%
- ICAD N/A
- EPS Growth
- GDL N/A
- ICAD N/A
- EPS
- GDL N/A
- ICAD N/A
- Revenue
- GDL N/A
- ICAD $19,608,000.00
- Revenue This Year
- GDL N/A
- ICAD $2.58
- Revenue Next Year
- GDL N/A
- ICAD $14.78
- P/E Ratio
- GDL N/A
- ICAD N/A
- Revenue Growth
- GDL N/A
- ICAD 13.22
- 52 Week Low
- GDL $7.65
- ICAD $1.18
- 52 Week High
- GDL $8.13
- ICAD $3.78
- Technical
- Relative Strength Index (RSI)
- GDL 55.90
- ICAD 77.56
- Support Level
- GDL $8.01
- ICAD $3.42
- Resistance Level
- GDL $8.15
- ICAD $3.58
- Average True Range (ATR)
- GDL 0.08
- ICAD 0.13
- MACD
- GDL 0.02
- ICAD 0.04
- Stochastic Oscillator
- GDL 83.33
- ICAD 90.07
About GDL GDL Fund The of Beneficial Interest
GDL Fund is a diversified closed-end management investment company. Its primary investment objective is to achieve absolute returns in various market conditions without excessive risk of capital. The fund seeks to achieve its objective by investing in merger arbitrage transactions and, to a lesser extent, in corporate reorganizations involving stubs, spin-offs, and liquidations.
About ICAD iCAD Inc.
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment includes image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.